Acquisition / mergerFiled on BSE ·

Sai Parenterals to acquire majority stake in Bion Therapeutics in cash deal

Sai Parenterals · Pharmaceuticals & Biotechnology

Arthneeti Research DeskPublished 1 min read
₹28.2 CrAcquisition / merger

Key highlights

  • Board approved acquisition via wholly owned subsidiary SP Analytics Private Limited on 16 Nov 2026
  • Bion Therapeutics (India) Pvt Ltd, incorporated in 2005, reported ₹28.22 Cr turnover for H1 FY 2026-27
  • Acquisition to complete by 30 Nov 2026, funded through IPO proceeds and debt, no regulatory approval needed

Original filing

Board Meeting Outcome for Outcome Of Board Meeting Held On Monday, 16Th November, 2026

Read the filing on BSE (PDF) →

Companies guiding to strong growth

Ranked by management's own guidance on revenue and margins — not by us.

Knowledge Marine

Engineering Services

Revenue growth 40%+Margin up 2%+

Sign up free to see all 6 →

See full rankings

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

More from Sai Parenterals

Other acquisition / merger filings this fortnight

All acquisition / merger filings →

Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.